T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
First Watch Restaurant Group
FWRG
$800M
| $457K | ﹤0.01% |
30,254
+5,925
| +24% | +$99.9K |
|
2427
Gogo Inc
GOGO
$377M
| $457K | ﹤0.01% |
98,024
+15,752
| +19% | +$115K |
|
2428
FLEX LNG
FLNG
$1.64B
| $456K | ﹤0.01% |
18,273
+1,149
| +7% | +$29.3K |
|
2429
Allient
ALNT
$1.86B
| $454K | ﹤0.01% |
8,445
+519
| +7% | +$27.1K |
|
2430
indie Semiconductor
INDI
$875M
| $454K | ﹤0.01% |
128,508
+26,492
| +26% | +$116K |
|
2431
Northeast Bank
NBN
$1.16B
| $451K | ﹤0.01% |
4,336
-42
| -1% | -$3.92K |
|
2432
Oxford Industries
OXM
$542M
| $451K | ﹤0.01% |
13,186
+3,504
| +36% | +$130K |
|
|
SKYT
2433
DELISTED
SkyWater Technology
SKYT
| $450K | ﹤0.01% |
24,718
-410,165
| -94% | -$7.13M |
|
2434
iShares Core S&P Small-Cap ETF
IJR
$113B
| $448K | ﹤0.01% |
3,724
| – | – |
|
2435
QuinStreet
QNST
$1.19B
| $448K | ﹤0.01% |
31,107
+1,391
| +5% | +$20.1K |
|
2436
Rigel Pharmaceuticals
RIGL
$762M
| $447K | ﹤0.01% |
10,434
+1,149
| +12% | +$43.3K |
|
2437
OraSure Technologies
OSUR
$277M
| $444K | ﹤0.01% |
183,285
+61,300
| +50% | +$161K |
|
2438
Butterfly Network
BFLY
$2.36B
| $443K | ﹤0.01% |
116,395
+14,446
| +14% | +$39.3K |
|
|
SEG
2439
Seaport Entertainment Group
SEG
$366M
| $442K | ﹤0.01% |
22,310
+4,700
| +27% | +$105K |
|
2440
Domo
DOMO
$187M
| $440K | ﹤0.01% |
52,110
-11,989
| -19% | -$141K |
|
2441
Nektar Therapeutics
NKTR
$2.57B
| $439K | ﹤0.01% |
10,376
-1,600
| -13% | -$89.5K |
|
2442
First United
FUNC
$298M
| $437K | ﹤0.01% |
11,672
+743
| +7% | +$27.6K |
|
2443
Tencent Music
TME
$14.2B
| $437K | ﹤0.01% |
24,903
-4,620,198
| -99% | -$93.7M |
|
|
PONY
2444
Pony AI Inc
PONY
$3.62B
| $437K | ﹤0.01% |
30,114
-6,547
| -18% | -$109K |
|
|
EB
2445
DELISTED
Eventbrite
EB
| $436K | ﹤0.01% |
97,819
+8,499
| +10% | +$26.3K |
|
2446
FTAI Infrastructure
FIP
$551M
| $436K | ﹤0.01% |
94,434
+36,447
| +63% | +$180K |
|
2447
Mercantile Bank Corp
MBWM
$1.06B
| $435K | ﹤0.01% |
9,036
+662
| +8% | +$30.5K |
|
2448
Malibu Boats
MBUU
$573M
| $433K | ﹤0.01% |
15,322
+1,129
| +8% | +$32.7K |
|
|
DCH
2449
Dauch Corp
DCH
$1.6B
| $432K | ﹤0.01% |
67,253
+6,126
| +10% | +$38.1K |
|
2450
Arbutus Biopharma
ABUS
$906M
| $430K | ﹤0.01% |
89,216
+6,208
| +7% | +$27.9K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.